<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font21">(.) </span>
   <span class="font19">with </span>
   <span class="font18">for </span>
   <span class="font17">patients </span>
   <span class="font15">was </span>
   <span class="font15">HCV </span>
   <span class="font15">therapy </span>
   <span class="font14">PWIDs </span>
   <span class="font14">treatment </span>
   <span class="font14">were </span>
   <span class="font13">hepatitis </span>
   <span class="font13">OST </span>
   <span class="font13">{background </span>
   <span class="font13">The </span>
   <span class="font13">not </span>
   <span class="font12">from </span>
   <span class="font12">;():–. </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">DAA </span>
   <span class="font12">G/P </span>
   <span class="font12">Suchthilfe </span>
   <span class="font12">patient </span>
   <span class="font12">SVR </span>
   <span class="font12">margin </span>
   <span class="font12">who </span>
   <span class="font12">{border-style </span>
   <span class="font12">virus </span>
   <span class="font12">weeks </span>
   <span class="font11">Wien </span>
   <span class="font11">according </span>
   <span class="font11">after </span>
   <span class="font11">antiviral </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">are </span>
   <span class="font11">drug </span>
   <span class="font11">observed </span>
   <span class="font11">that </span>
   <span class="font11">(.%) </span>
   <span class="font11">data </span>
   <span class="font11">chronic </span>
   <span class="font11">ongoing </span>
   <span class="font11">received </span>
   <span class="font11">high </span>
   <span class="font11">study </span>
   <span class="font11">their </span>
   <span class="font11">this </span>
   <span class="font11">treated </span>
   <span class="font11">(%)] </span>
   <span class="font11">Medicine </span>
   <span class="font11">liver </span>
   <span class="font11">our </span>
   <span class="font11">review </span>
   <span class="font11">therapy. </span>
   <span class="font11">&amp;amp; </span>
   <span class="font11">directly </span>
   <span class="font11">included </span>
   <span class="font11">one </span>
   <span class="font11">support </span>
   <span class="font11">without </span>
   <span class="font11">Health </span>
   <span class="font11">did </span>
   <span class="font11">gGmbH </span>
   <span class="font11">lost </span>
   <span class="font11">risk </span>
   <span class="font11">Hepatol. </span>
   <span class="font11">IDU </span>
   <span class="font11">Sciences </span>
   <span class="font11">end </span>
   <span class="font11">excellent </span>
   <span class="font11">fibrosis </span>
   <span class="font11">non-adherence </span>
   <span class="font11">only </span>
   <span class="font11">pathogens </span>
   <span class="font11">these </span>
   <span class="font10">Biology </span>
   <span class="font10">Vienna </span>
   <span class="font10">Viral </span>
   <span class="font10">all </span>
   <span class="font10">facility </span>
   <span class="font10">genotype </span>
   <span class="font10">have </span>
   <span class="font10">infection </span>
   <span class="font10">rates </span>
   <span class="font10">sciences </span>
   <span class="font10">DOT </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">Patients </span>
   <span class="font10">Treatment </span>
   <span class="font10">Vienna, </span>
   <span class="font10">concept </span>
   <span class="font10">curationInvestigationWriting </span>
   <span class="font10">glecaprevir/pibrentasvir </span>
   <span class="font10">health </span>
   <span class="font10">low-threshold </span>
   <span class="font10">population </span>
   <span class="font10">px; </span>
   <span class="font10">standard </span>
   <span class="font10">use </span>
   <span class="font10">{font-family </span>
   <span class="font10">Ambulatorium </span>
   <span class="font10">Gilead, </span>
   <span class="font10">Therapy </span>
   <span class="font10">adherence </span>
   <span class="font10">font-size </span>
   <span class="font10">had </span>
   <span class="font10">history </span>
   <span class="font10">inject </span>
   <span class="font10">kPa </span>
   <span class="font10">medical </span>
   <span class="font10">missed </span>
   <span class="font10">order </span>
   <span class="font10">presumed </span>
   <span class="font10">provided </span>
   <span class="font10">rate </span>
   <span class="font10">relevant </span>
   <span class="font10">results </span>
   <span class="font10">safety </span>
   <span class="font10">setting </span>
   <span class="font10">using </span>
   <span class="font10">well </span>
   <span class="font10">world </span>
   <span class="font10">APRI </span>
   <span class="font10">Abbvie, </span>
   <span class="font10">Antiviral </span>
   <span class="font10">HCV-RNA </span>
   <span class="font10">Hepatol </span>
   <span class="font10">Lancet </span>
   <span class="font10">This </span>
   <span class="font10">Yet, </span>
   <span class="font10">achieved </span>
   <span class="font10">care </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">clinic </span>
   <span class="font10">concerning </span>
   <span class="font10">conflicts </span>
   <span class="font10">difficult-to-treat </span>
   <span class="font10">distribution </span>
   <span class="font10">double; </span>
   <span class="font10">effectiveness </span>
   <span class="font10">employed </span>
   <span class="font10">including </span>
   <span class="font10">interest. </span>
   <span class="font10">life </span>
   <span class="font10">opioid </span>
   <span class="font10">outpatient </span>
   <span class="font10">patients. </span>
   <span class="font10">people </span>
   <span class="font10">poor </span>
   <span class="font10">real </span>
   <span class="font10">related </span>
   <span class="font10">specific </span>
   <span class="font10">study. </span>
   <span class="font10">substitution </span>
   <span class="font10">tertiary </span>
   <span class="font10">three </span>
   <span class="font10">under </span>
   <span class="font10">virologic </span>
   <span class="font10"> Not </span>
   <span class="font10">./S-()- </span>
   <span class="font10">DOT-group </span>
   <span class="font10">IDU. </span>
   <span class="font10">ITT </span>
   <span class="font10">Microbial </span>
   <span class="font10">SchwablP, </span>
   <span class="font10">Study </span>
   <span class="font10">[Internet]. </span>
   <span class="font10">achieve </span>
   <span class="font10">adverse </span>
   <span class="font10">along </span>
   <span class="font10">analysis </span>
   <span class="font10">authors </span>
   <span class="font10">basis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">compared </span>
   <span class="font10">compliance </span>
   <span class="font10">cure </span>
   <span class="font10">decision </span>
   <span class="font10">defined </span>
   <span class="font10">direct-acting </span>
   <span class="font10">drugs </span>
   <span class="font10">efficacy </span>
   <span class="font10">has </span>
   <span class="font10">ingestion </span>
   <span class="font10">intravenous </span>
   <span class="font10">laboratory </span>
   <span class="font10">median </span>
   <span class="font10">patients, </span>
   <span class="font10">percentage </span>
   <span class="font10">pharmacy </span>
   <span class="font10">phase </span>
   <span class="font10">reasons </span>
   <span class="font10">reported </span>
   <span class="font10">screening </span>
   <span class="font10">solid; </span>
   <span class="font10">stage </span>
   <span class="font10">sustained </span>
   <span class="font10">together </span>
   <span class="font10">transient </span>
   <span class="font10">treat </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;lt;. </span>
   <span class="font10">./j.jhep... </span>
   <span class="font10">.–.%) </span>
   <span class="font10">All </span>
   <span class="font10">Antivirals </span>
   <span class="font10">Austria[], </span>
   <span class="font10">CI: </span>
   <span class="font10">Chronic </span>
   <span class="font10">DOT, </span>
   <span class="font10">DoreGJ, </span>
   <span class="font10">Drug </span>
   <span class="font10">European </span>
   <span class="font10">Flaviviruses </span>
   <span class="font10">Hepacivirus: </span>
   <span class="font10">Hospital </span>
   <span class="font10">However, </span>
   <span class="font10">IQR </span>
   <span class="font10">IU/L </span>
   <span class="font10">Life </span>
   <span class="font10">Liver </span>
   <span class="font10">MSD, </span>
   <span class="font10">Microbiology </span>
   <span class="font10">MoserS, </span>
   <span class="font10">OST, </span>
   <span class="font10">One </span>
   <span class="font10">Virus </span>
   <span class="font10">Wien, </span>
   <span class="font10">acting </span>
   <span class="font10">additional </span>
   <span class="font10">alongside </span>
   <span class="font10">analysis, </span>
   <span class="font10">analysis. </span>
   <span class="font10">any </span>
   <span class="font10">assessment </span>
   <span class="font10">attend </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">but </span>
   <span class="font10">cannot </span>
   <span class="font10">center </span>
   <span class="font10">cirrhosis, </span>
   <span class="font10">clinical </span>
   <span class="font10">cohort </span>
   <span class="font10">collection </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">design, </span>
   <span class="font10">elimination </span>
   <span class="font10">em; </span>
   <span class="font10">especially </span>
   <span class="font10">events </span>
   <span class="font10">follow-up </span>
   <span class="font10">form </span>
   <span class="font10">injection </span>
   <span class="font10">known </span>
   <span class="font10">limited </span>
   <span class="font10">mITT </span>
   <span class="font10">management </span>
   <span class="font10">most </span>
   <span class="font10">number </span>
   <span class="font10">outcomes </span>
   <span class="font10">preparation </span>
   <span class="font10">prevalence </span>
   <span class="font10">program </span>
   <span class="font10">psychiatric </span>
   <span class="font10">pt;} </span>
   <span class="font10">publish, </span>
   <span class="font10">recent </span>
   <span class="font10">reinfection </span>
   <span class="font10">represents </span>
   <span class="font10">response </span>
   <span class="font10">role </span>
   <span class="font10">self-administration </span>
   <span class="font10">showed </span>
   <span class="font10">showing </span>
   <span class="font10">socioeconomic </span>
   <span class="font10">stable </span>
   <span class="font10">staff </span>
   <span class="font10">stiffness </span>
   <span class="font10">team </span>
   <span class="font10">therapy; </span>
   <span class="font10">travel </span>
   <span class="font10">would </span>
  </p>
 </body>
</html>
